Multidisciplinary Outpatient Congestive Heart Failure Clinic: Impact on Hospital Admissions and Emergency Room Visits
Overview
Affiliations
Background: Life-saving drugs, such as angiotensin-converting enzyme inhibitors and beta-blockers, are frequently underused and underdosed in patients with heart failure. Specialized clinics have been shown to provide additional benefits.
Objectives: To determine the impact of a multidisciplinary outpatient heart failure clinic on the frequency of cardiovascular readmissions and emergency room (ER) visits, length of inpatient and ER stays, and New York Heart Association (NYHA) class.
Methods: A retrospective chart review study comprising 72 patients who had two or more visits to a heart failure clinic between December 1, 1998, and August 31, 1999, was performed. The number of readmissions and ER visits, and the NYHA class were recorded during the six-month period before and after the first visit to the clinic.
Results: Most subjects were in NYHA class III or IV (71% and 21%, respectively), and the mean ejection fraction was 31%. The post- versus preintervention relative risk of readmission was 0.43 (95% CI 0.25 to 0.72). The total number of inpatient days decreased by 54% (95% CI 44% to 62%). The post- versus preintervention relative risk of an ER visit was 0.29 (95% CI 0.19 to 0.45). The number of ER days decreased by 60% (95% CI 41% to 73%). NYHA functional class significantly improved, with most subjects ending the six-month postintervention period in class I or II (33% and 49%, respectively; P=0.001).
Conclusions: This multidisciplinary heart failure clinic significantly decreased the risk of cardiovascular readmissions and subsequent ER visits. It led to improvement in NYHA class and to a decrease in the number of days spent in the hospital and in the ER.
Luk A, Wang V, Almazroa L, Foroutan F, Huebener N, Hillyer A CJC Open. 2020; 2(4):229-235.
PMID: 32695973 PMC: 7365826. DOI: 10.1016/j.cjco.2020.02.010.
Saudi Heart Association (SHA) guidelines for the management of heart failure.
AlHabeeb W, Al-Ayoubi F, Alghalayini K, Al Ghofaili F, Al Hebaishi Y, Al-Jazairi A J Saudi Heart Assoc. 2019; 31(4):204-253.
PMID: 31371908 PMC: 6660461. DOI: 10.1016/j.jsha.2019.06.004.
Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s).
Bouabdallaoui N, Ducharme A Curr Heart Fail Rep. 2018; 15(6):357-367.
PMID: 30251188 DOI: 10.1007/s11897-018-0412-x.
CSI position statement on management of heart failure in India.
Guha S, Harikrishnan S, Ray S, Sethi R, Ramakrishnan S, Banerjee S Indian Heart J. 2018; 70 Suppl 1:S1-S72.
PMID: 30122238 PMC: 6097178. DOI: 10.1016/j.ihj.2018.05.003.
Geva A, Olson K, Liu C, Mandl K Med Care Res Rev. 2017; 76(1):115-128.
PMID: 29148301 PMC: 5748352. DOI: 10.1177/1077558717718626.